Regenerative Medicine in Ocular Therapy: What Applications are in Clinical Translation On-Demand eCast (AABB Center for Cellular Therapies), August 18, 2016-August 18, 2018
Description: Regenerative medicine has emerged as an innovative scientific field that focuses on the development of new approaches to repairing cells, tissues and organs for clinical applications. This program provided insights into the rapidly evolving field of ocular therapy in regenerative medicine. It also highlighted technologies that have been applied in patients as well as those that are currently in development.

Adipose-Derived Stem Cell Banking for Reconstructive and Regenerative Medicine On-Demand eCast (AABB Center for Cellular Therapies), June 22, 2016-June 22, 2018
Description: The importance of stem cells in regenerating or repairing damaged or diseased tissues is well established; however, there are considerations to be made in employing stem cells clinically. The source of the cells, how they are isolated and cultured impact patient outcomes. Adipose tissue may be a rich and convenient source of cells for regenerative medicine therapeutic approaches. Adipose-derived stem cells, a type of mesenchymal stromal cell, are considered to be very effective for their pluripotency, proliferative efficiency, and low donor morbidity. This program discussed adipose-derived stromal cell isolation and culture for stem cell banking and therapeutic applications. Knowledge obtained will help to improve understanding of culture and banking practices that impact clinical effectiveness.

Perinatal Stem Cells from Umbilical Cord Tissue and Their Potential Use in Newborns with Hypoxic Ischemic Injuries (Save the Cord Foundation), September 2016 
Description: Morey Kraus is the Chief Scientific Officer of the Diagnostics division of PerkinElmer, Inc. where he oversees scientific affairs for the maternal fetal health business. In this webinar, Mr. Kraus speaks on the potential use of perinatal stem cells from umbilical cord tissue and their potential use in newborns with hypoxic ischemic injuries. Exciting research is happening using these cells and Mr. Kraus will share his valuable insight on the subject.

Can we prevent or cure diabetes with cord blood? The CoRD Study (Save the Cord Foundation), August 2016 
Description: Dr. Maria Craig, professor of pediatric endocrinology, the University of Sydney and Sydney Children’s Hospital Network, discusses the CoRD study (Cord blood Reinfusion in Diabetes). This pioneering study represents a world-first in using cord blood to potentially treat or even cure Type 1 diabetes.

Women’s Health: Perinatal Stem Cells in Regenerative Medicine (Save the Cord Foundation), May 2016
Description: Dr. Cetrulo, Sr. discusses the importance of perinatal stem cells and the impact they will have on treating a variety of diseases. In particular, Dr. Cetrulo, Sr. discusses how he anticipates that in the near future people who go to emergency rooms with chest pain, with the presumptive diagnosis of a heart attack, or myocardial infarction (MI), will be given an off-the-shelf stem cell preparation to prevent heart muscle damage.

Recycling Matters – Cord-Derived Stem Cell Treatment of Neonatal Diseases (Save the Cord Foundation), April 2016 
Description: Dr. Bernard Thébaud, neonatologist at the Children’s Hospital of Eastern Ontario and a senior scientist with the Ottawa Hospital Research Institute and Children’s Hospital of Eastern Ontario Research Institute, discusses using cord blood derived stem cell therapy to improve lung disease and repair organ damage in premature infants.

The New Regulatory Framework for Regenerative Medicine In Japan (ISCT), February 2016
Description: Regenerative medicine techniques use living tissues or cells to treat intractable diseases or reconstruct organs. With these techniques, however, there comes inherent risk, such as viral infection and tumorigenicity of stem cells. Thus, it is necessary for the regulation of regenerative medicine to evolve to meet the unique characteristics, particular to regenerative medicine. The government of Japan has made a nation-wide effort in preparation for innovative regenerative medicine, ensuring to promote research while also focusing on safety assurance. The regulatory guidelines for regenerative medicine have been reexamined and the (revised) Pharmaceutical Affairs Law (PAL), which was renamed as the Pharmaceuticals, Medical Devices and Other Therapeutic Products Act (PMD Act), and the Act on the Safety of Regenerative Medicine were implemented in November of 2014 in Japan. Based on these recent changes in the national framework for regenerative medicine in Japan, we will introduce the current framework, outlining the significant changes and how it provides a breeding ground for cutting-edge, creative approaches to medicine based on innovative ideas, and ground-breaking research.

Autologous Cord Blood Stem Cell Applications for Pediatric Stroke and Acquired Hearing Loss (Save the Cord Foundation), December 2015 
Description: Comprehensive Pediatric Epilepsy Center, Florida Hospital for Children, speak about using cord blood to treat acquired hearing loss and perinatal stroke in children.

Novel Applications for Newborn Stem Cells: Exploring Regenerative Properties (Save the Cord Foundation), June 2015
Description: Watch the recorded webinar to hear Kate Girard, Director of Clinical Affairs and Regenerative Medicine at ViaCord, speak about the novel applications for newborn stem cells, current regenerative medicine applications of cord blood stem cells, and potential future applications of cord-tissue-derived stem cells.

Back to Allied Learning Center



FACT Consulting

Accreditation Success Story

The Héma-Québec Public Cord Blood Bank (CBB) was created in 2004 to meet the needs of Quebecers and to contribute to the international effort towards a high-quality global inventory of cord blood units. Read more